Cannabis Clinical Trial
Official title:
Pilot fMRI Studies of THC Effects on Memory and Reward Learning
Tetrahydrocannabidiol (THC) is the psychoactive chemical in cannabis that makes people high. This study aims to dissect acute impairment of various forms of memory and learning by THC in cannabis compared to placebo. Impairment will be assessed via a short cognitive test battery and then subjects will complete four tasks in the fMRI scanner.
Status | Recruiting |
Enrollment | 20 |
Est. completion date | December 2025 |
Est. primary completion date | December 2024 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 55 Years |
Eligibility | Inclusion Criteria: - 18-55 years old - Right handed - CNB use within past 2 years and felt "high" when used - Able to read, speak, and understand English - Able and willing to provide written informed consent, and willing to commit to study protocol. Exclusion Criteria: - Current marijuana tolerance, desire to cut down, or cravings to sue during periods of abstinence. - Strongly left-handed - Positive screen for drug or alcohol (except CNB) on test day will result in rescheduling the appointment - History of adverse effects with CNB - CNB users who are abstaining - Report of any psychotic disorder in a first degree relative - IQ < 80 on the Wechsler Abbreviated Scale of Intelligence - Inability to comprehend written instructions using the WRAT-4 reading achievement test - Pregnant, breastfeeding, and ineffective birth control methods. - Unable or unsafe to have an MRI - Serious medical, neuro-ophthalmological, or neurological illness (e.g. cancer, seizure disorders, encephalopathy - History of head trauma with loss of consciousness > 30 minutes or concussion lasting 30 days. - Focal brain lesion seen on structural MRI - Any medical/neurological condition that could compromise neurocognitive performance (e.g. epilepsy, multiple sclerosis, fetal alcohol syndrome). - Anyone deemed unsafe to study personnel for any reason |
Country | Name | City | State |
---|---|---|---|
United States | Hartford Hospital | Hartford | Connecticut |
Lead Sponsor | Collaborator |
---|---|
Hartford Hospital | Yale University |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Marijuana induced performance changes on fMRI Multi-Stage Decision Making (MSDM) Task. | The MSDM is a reinforcement learning paradigm that quantifies the degree to which subjects can integrate recent trial-to-trial information about a stimulus' likelihood of reward with acquired knowledge about whether some choices generally lead to disadvantageous outcomes vs. others that more often lead to reward. | Baseline and post drug administration at 10 minutes. | |
Primary | Marijuana induced performance changes on Relational and Item Specific Coding (RISE) fMRI Task. | The RISE task is a hippocampal-dependent learning paradigm that assesses declarative memory. | Baseline and post drug administration at 10 minutes. | |
Primary | Marijuana induced performance changes on fMRI Treadway/Effort Reward Task. | The Treadway Effort/Reward Task independently measures the neural responses to two dimensions of a cost/benefit decision: the effort required and the magnitude of reward. | Baseline and post drug administration at 10 minutes. | |
Primary | Marijuana induced performance changes on fMRI Monetary Incentive Delay (MID) Task. | The MID task probes the brain's reward system to assess the anticipation and receipt of rewards or punishment. | Baseline and post drug administration at 10 minutes. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04284813 -
Families With Substance Use and Psychosis: A Pilot Study
|
N/A | |
Completed |
NCT04199468 -
THC and Ketamine Effects in Humans: Relation to Neural Oscillations and Psychosis
|
Phase 1 | |
Completed |
NCT04587700 -
Analgesic Consumption in Chronic Marijuana Users Following Orthopedic Trauma Surgery
|
||
Not yet recruiting |
NCT05899946 -
An Integrated Program to Promote Anti-cannabis Messages
|
N/A | |
Active, not recruiting |
NCT02735954 -
Colorado Marijuana Users Health Cohort
|
||
Completed |
NCT00842985 -
Dronabinol Interactions in Humans
|
N/A | |
Completed |
NCT04124432 -
Behavioral Pharmacology of Cannabis and Nicotine
|
Phase 1 | |
Active, not recruiting |
NCT04693884 -
Cannabis Inhalation: Effects on Cardiovascular Function During Rest and Exercise
|
Early Phase 1 | |
Recruiting |
NCT03078309 -
The Effects of Cannabis on Visual Functions in Healthy and Retinitis Pigmentosa Patients
|
Early Phase 1 | |
Active, not recruiting |
NCT03560934 -
Tetrahydrocannabinol (THC) and Sleep
|
Early Phase 1 | |
Recruiting |
NCT04704271 -
Gender Related Differences in the Acute Effects of Delta-9-Tetrahydrocannabinol in Healthy Humans: Sub-Study II
|
Phase 1 | |
Withdrawn |
NCT03245658 -
The Effect of Cannabis in Pancreatic Cancer
|
Phase 2 | |
Completed |
NCT04911127 -
Therapeutic Response of Cannabidiol in Rheumatoid Arthritis
|
Phase 1 | |
Not yet recruiting |
NCT05999383 -
Understanding the Clinical Pharmacology of Marijuana-Tobacco Co-administration
|
Phase 2 | |
Recruiting |
NCT04429568 -
THC Crossover Study
|
N/A | |
Completed |
NCT05554146 -
Pain Inflammation and Cannabis in HIV
|
N/A | |
Not yet recruiting |
NCT05320367 -
A Study of Inhaled Cannabidiol in Healthy Occasional Cannabis Users
|
Phase 1/Phase 2 | |
Terminated |
NCT03251326 -
Nabilone in Cannabis Users With PTSD
|
Phase 1/Phase 2 | |
Completed |
NCT02567344 -
Excitatory rTMS to the Left Dorsolateral Pre-Frontal Cortex to Reduce Cannabis-Cue Induced Craving
|
N/A | |
Completed |
NCT00176085 -
Pharmacokinetics of THCCOOH and Its Acyl-glucuronide After Intravenous Administration of THCCOOH
|
Phase 1 |